Repositorio Dspace

AI-Based Phenotyping of Atrial Fibrillation Through Generative Topographic Mapping: Prospective Murcia Atrial Fibrillation Project III Cohort Study

Mostrar el registro sencillo del ítem

dc.contributor.author Soler-Espejo, Eva
dc.contributor.author Chen, Yang
dc.contributor.author Ramos-Bratos, María-Pilar
dc.contributor.author Ortega-Martorell, Sandra
dc.contributor.author Olier, Ivan
dc.contributor.author Rivera-Caravaca, José-Miguel
dc.contributor.author Mar, Francisco
dc.contributor.author Roldán-Schilling, Vanessa
dc.contributor.author Lip, Gregory-Y-H
dc.date.accessioned 2026-10-28T08:14:53Z
dc.date.available 2026-10-28T08:14:53Z
dc.date.issued 2026-08-06
dc.identifier.citation Soler Espejo E, Chen Y, Ramos-Bratos MP, Ortega-Martorell S, Olier I, Rivera-Caravaca JM, et al. AI-Based Phenotyping of Atrial Fibrillation Through Generative Topographic Mapping: Prospective Murcia Atrial Fibrillation Project III Cohort Study. J Med Internet Res. 6 de agosto de 2026;28:e90502. doi:10.2196/90502
dc.identifier.issn 1439-4456
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28999
dc.description.abstract BACKGROUND: The clinical heterogeneity of atrial fibrillation (AF) challenges current classifications and risk scores, limiting their real-world applicability. AI-driven methods may enhance phenotyping and risk stratification. OBJECTIVE: This study aimed to apply a generative topographic mapping (GTM)-based clustering approach to a large, real-world, prospective AF cohort to identify clinically relevant phenotypes and assess their associations with clinical outcomes. METHODS: We conducted a prospective observational cohort study including consecutive adult outpatients with newly diagnosed AF who initiated oral anticoagulation between January 2016 and November 2021. Cardiometabolic risk was modeled as a multidimensional construct integrating cardiovascular and metabolic comorbidities. GTM was applied to project high-dimensional clinical data into a low-dimensional latent space, enabling probabilistic patient representation and visualization of phenotypic structure. Unsupervised hierarchical clustering using Ward's method was performed on the latent space to identify AF phenotypes, and patients were assigned to clusters based on their highest posterior probability. Clinical outcomes, including thromboembolic events, major bleeding, major adverse cardiovascular events (MACE), cardiovascular death, and all-cause death, were assessed over a maximum follow-up of 2 years. Nonfatal outcomes were analyzed using Fine-Gray competing-risk models and reported as subdistribution hazard ratios (sHRs), whereas cardiovascular and all-cause death were analyzed using adjusted Cox proportional hazards models and reported as adjusted hazard ratios (aHRs). RESULTS: Among 3259 patients with AF (median age 77, IQR 70-83 years; 1721/3259, 52.8% female; mean follow-up 1.81 years), four phenotypes emerged: (1) older with highest cardiometabolic burden, (2) older with lower cardiometabolic risk, (3) comparatively younger with intermediate-high cardiometabolic risk, and (4) comparatively younger with intermediate cardiometabolic risk. Compared with phenotype 1, phenotype 4 demonstrated lower risks of thromboembolic events (sHR 0.70, 95% CI 0.50-0.98), major bleeding (sHR 0.61, 95% CI 0.42-0.89), and MACE (sHR 0.67, 95% CI 0.47-0.94). Regarding cardiovascular and all-cause death, all phenotypes demonstrated a lower risk compared with phenotype 1: phenotype 2 (aHR 0.52, 95% CI 0.33-0.85; and aHR 0.66, 95% CI 0.50-0.87, respectively), phenotype 3 (aHR 0.57, 95% CI 0.32-0.99; and aHR 0.44, 95% CI 0.30-0.65, respectively), and phenotype 4 (aHR 0.49, 95% CI 0.33-0.72; and aHR 0.56, 95% CI 0.44-0.71, respectively). However, these associations were attenuated after further adjustment for age, sex, and major comorbidities, with phenotype 4 retaining a significant association with lower cardiovascular death and phenotypes 3 and 4 retaining significant associations with lower all-cause death. CONCLUSIONS: GTM-based clustering analysis identified prognostically distinct AF phenotypes, highlighting the potential of machine learning approaches to support personalized AF care. Further external validation is needed to establish the generalizability of these findings.
dc.language.iso eng
dc.publisher JMIR PUBLICATIONS, INC
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Atrial Fibrillation
dc.subject.mesh Female
dc.subject.mesh Phenotype
dc.subject.mesh Prospective Studies
dc.subject.mesh Male
dc.subject.mesh Aged
dc.subject.mesh Clustering Algorithms
dc.subject.mesh Artificial Intelligence
dc.subject.mesh Generative Artificial Intelligence
dc.subject.mesh Middle Aged
dc.subject.mesh Cohort Studies
dc.subject.mesh Cluster Analysis
dc.title AI-Based Phenotyping of Atrial Fibrillation Through Generative Topographic Mapping: Prospective Murcia Atrial Fibrillation Project III Cohort Study
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42562389
dc.relation.publisherversion https://www.jmir.org/2026/1/e90502
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.2196/90502
dc.journal.title Journal of Medical Internet Research
dc.identifier.essn 1438-8871


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta